Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,079 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discovery of RORγ Allosteric Fluorescent Probes and Their Application: Fluorescence Polarization, Screening, and Bioimaging.
Yu YC, Tong ZJ, Liang XT, Wu JZ, Xu YJ, Wang JJ, Zhang MY, Wei TH, Yang J, Wang YB, Wang QX, Li QQ, Wang Z, Leng X, Ding N, Xue X, Sun SL, Li NG, Wang XL. Yu YC, et al. Among authors: wang jj, wang z, wang xl, wang qx, wang yb. J Med Chem. 2024 Mar 14;67(5):4194-4224. doi: 10.1021/acs.jmedchem.4c00058. Epub 2024 Mar 5. J Med Chem. 2024. PMID: 38442261
Synthesis and biological evaluation of 4-(4-aminophenyl)-6-methylisoxazolo[3,4-b] pyridin-3-amine covalent inhibitors as potential agents for the treatment of acute myeloid leukemia.
Kang JB, Chen L, Leng XJ, Wang JJ, Cheng Y, Wu SH, Ma YY, Yang LJ, Cao YH, Yang X, Tong ZJ, Wu JZ, Wang YB, Zhou H, Liu JC, Ding N, Dai WC, Yu YC, Xue X, Sun SL, Dai XB, Chang L, Wang XL, Li NG, Shi ZH. Kang JB, et al. Among authors: wang jj, wang xl, wang yb. Bioorg Med Chem. 2022 Sep 15;70:116937. doi: 10.1016/j.bmc.2022.116937. Epub 2022 Jul 16. Bioorg Med Chem. 2022. PMID: 35863236
Discovery of 4-(4-aminophenyl)-6-phenylisoxazolo[3,4-b]pyridine-3-amine derivatives as novel FLT3 covalent inhibitors for the intervention of acute myeloid leukemia.
Wang QX, Wang YB, Sha JK, Zhou H, Liu JC, Wu JZ, Tong ZJ, Cai J, Chen ZJ, Zhang CQ, Zheng XR, Wang JJ, Wang XL, Xue X, Yu YC, Ding N, Leng XJ, Dai WC, Sun SL, Chang L, Li NG, Shi ZH. Wang QX, et al. Among authors: wang jj, wang xl, wang yb. Drug Dev Res. 2023 Apr;84(2):296-311. doi: 10.1002/ddr.22032. Epub 2023 Jan 16. Drug Dev Res. 2023. PMID: 36644989
Design and synthesis of selective FLT3 inhibitors via exploration of back pocket II.
Wang QX, Cao YH, Yang LJ, Ma YY, Li N, Wu SH, Chen L, Wu JZ, Tong ZJ, Wang XL, Xue X, Ding N, Leng XJ, Chang L, Dai WC, Yu YC, Sun SL, Yang Y, Li NG, Shi ZH. Wang QX, et al. Among authors: wang xl. Future Med Chem. 2023 Jan;15(1):57-71. doi: 10.4155/fmc-2022-0231. Epub 2023 Jan 18. Future Med Chem. 2023. PMID: 36651264
Design and synthesis 1H-Pyrrolo[2,3-b]pyridine derivatives as FLT3 inhibitors for the treatment of Acute myeloid Leukemia.
Wei TH, Zhou Y, Yang J, Zhang MY, Wang JJ, Tong ZJ, Wu JZ, Wang YB, Sha JK, Chen M, Ding N, Yu YC, Dai WC, Leng XJ, Xue X, Sun SL, Wang XL, Li NG, Shi ZH. Wei TH, et al. Among authors: wang jj, wang xl, wang yb. Bioorg Med Chem. 2024 Feb 15;100:117631. doi: 10.1016/j.bmc.2024.117631. Epub 2024 Feb 2. Bioorg Med Chem. 2024. PMID: 38330848
4,079 results